Save information for later
Sign Up

Learn About Protoporphyria

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Protoporphyria Local Doctors?
Elite in Protoporphyria
Elite in Protoporphyria
Milan, IT 

Francesca Granata practices in Milan, Italy. Ms. Granata is rated as an Elite expert by MediFind in the treatment of Protoporphyria. Her top areas of expertise are Erythropoietic Protoporphyria, Protoporphyria, Porphyria, and Acute Intermittent Porphyria.

Elite in Protoporphyria
Elite in Protoporphyria
Zurich, ZH, CH 

Jasmin Barman-Aksozen practices in Zurich, Switzerland. Ms. Barman-Aksozen is rated as an Elite expert by MediFind in the treatment of Protoporphyria. Her top areas of expertise are Porphyria, Protoporphyria, Erythropoietic Protoporphyria, and Acute Hepatic Porphyria (AHP).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Protoporphyria
Elite in Protoporphyria
Parkville, VIC, AU 

Gayle Ross practices in Parkville, Australia. Ms. Ross is rated as an Elite expert by MediFind in the treatment of Protoporphyria. Her top areas of expertise are Erythropoietic Protoporphyria, Protoporphyria, Porphyria, and Porphyria Cutanea Tarda.

What are the latest Protoporphyria Clinical Trials?
A Phase 3, Multicenter, Open-label, Long-term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Summary: To evaluate the long-term safety and tolerability of oral dersimelagon.

Match to trials
Find the right clinical trials for you in under a minute
Get started
APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Summary: The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin increases pain-free sunlight exposure after 6 months of treatment in participants with EPP or XLP. * How PPIX concentration levels change from before bitopertin treatment to after 6 months of treatment. Res...